{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 37658
    }
  },
  "results": [
    {
      "safetyreportversion": "1",
      "safetyreportid": "10005501",
      "primarysourcecountry": "US",
      "occurcountry": "US",
      "transmissiondateformat": "102",
      "transmissiondate": "20141002",
      "reporttype": "2",
      "serious": "1",
      "seriousnessother": "1",
      "receivedateformat": "102",
      "receivedate": "20140313",
      "receiptdateformat": "102",
      "receiptdate": "20140313",
      "fulfillexpeditecriteria": "1",
      "companynumb": "US-ROCHE-1361301",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "ROCHE",
        "duplicatenumb": "US-ROCHE-1361301"
      },
      "primarysource": {
        "reportercountry": "US",
        "qualification": "1"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "69",
        "patientonsetageunit": "801",
        "patientsex": "2",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Febrile neutropenia",
            "reactionoutcome": "6"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "HERCEPTIN",
            "drugauthorizationnumb": "103792",
            "drugstructuredosagenumb": "6",
            "drugstructuredosageunit": "007",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "3",
            "drugintervaldosagedefinition": "803",
            "drugdosagetext": "1L",
            "drugdosageform": "SOLUTION FOR INFUSION",
            "drugadministrationroute": "065",
            "drugindication": "BREAST CANCER METASTATIC",
            "actiondrug": "5",
            "openfda": {
              "application_number": [
                "BLA103792"
              ],
              "brand_name": [
                "HERCEPTIN"
              ],
              "generic_name": [
                "TRASTUZUMAB"
              ],
              "manufacturer_name": [
                "Genentech, Inc."
              ],
              "product_ndc": [
                "50242-132"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "INTRAVENOUS"
              ],
              "substance_name": [
                "TRASTUZUMAB"
              ],
              "rxcui": [
                "1922509",
                "1922512"
              ],
              "spl_id": [
                "7517f775-6a10-4ddd-8dfb-6704ece413d0"
              ],
              "spl_set_id": [
                "492dbdb2-077e-4064-bff3-372d6af0a7a2"
              ],
              "package_ndc": [
                "50242-132-01"
              ],
              "nui": [
                "N0000175661",
                "N0000020008"
              ],
              "pharm_class_epc": [
                "HER2/neu Receptor Antagonist [EPC]"
              ],
              "pharm_class_moa": [
                "HER2/Neu/cerbB2 Antagonists [MoA]"
              ],
              "unii": [
                "P188ANX8CK"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "HERCEPTIN",
            "drugauthorizationnumb": "103792",
            "drugstructuredosagenumb": "420",
            "drugstructuredosageunit": "007",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "3",
            "drugintervaldosagedefinition": "803",
            "drugdosagetext": "2L",
            "drugadministrationroute": "065",
            "actiondrug": "5",
            "openfda": {
              "application_number": [
                "BLA103792"
              ],
              "brand_name": [
                "HERCEPTIN"
              ],
              "generic_name": [
                "TRASTUZUMAB"
              ],
              "manufacturer_name": [
                "Genentech, Inc."
              ],
              "product_ndc": [
                "50242-132"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "INTRAVENOUS"
              ],
              "substance_name": [
                "TRASTUZUMAB"
              ],
              "rxcui": [
                "1922509",
                "1922512"
              ],
              "spl_id": [
                "7517f775-6a10-4ddd-8dfb-6704ece413d0"
              ],
              "spl_set_id": [
                "492dbdb2-077e-4064-bff3-372d6af0a7a2"
              ],
              "package_ndc": [
                "50242-132-01"
              ],
              "nui": [
                "N0000175661",
                "N0000020008"
              ],
              "pharm_class_epc": [
                "HER2/neu Receptor Antagonist [EPC]"
              ],
              "pharm_class_moa": [
                "HER2/Neu/cerbB2 Antagonists [MoA]"
              ],
              "unii": [
                "P188ANX8CK"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "PERJETA",
            "drugauthorizationnumb": "125409",
            "drugstructuredosagenumb": "420",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "3",
            "drugintervaldosagedefinition": "803",
            "drugdosagetext": "1L",
            "drugdosageform": "SOLUTION FOR INFUSION",
            "drugadministrationroute": "065",
            "drugindication": "BREAST CANCER METASTATIC",
            "actiondrug": "5",
            "openfda": {
              "application_number": [
                "BLA125409"
              ],
              "brand_name": [
                "PERJETA"
              ],
              "generic_name": [
                "PERTUZUMAB"
              ],
              "manufacturer_name": [
                "Genentech, Inc."
              ],
              "product_ndc": [
                "50242-145"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "INTRAVENOUS"
              ],
              "substance_name": [
                "PERTUZUMAB"
              ],
              "rxcui": [
                "1298948",
                "1298953"
              ],
              "spl_id": [
                "dfebfe9c-a0c5-41d8-bf11-ed643627e264"
              ],
              "spl_set_id": [
                "17f85d17-ab71-4f5b-9fe3-0b8c822f69ff"
              ],
              "package_ndc": [
                "50242-145-01"
              ],
              "nui": [
                "N0000175661",
                "N0000020008"
              ],
              "pharm_class_epc": [
                "HER2/neu Receptor Antagonist [EPC]"
              ],
              "pharm_class_moa": [
                "HER2/Neu/cerbB2 Antagonists [MoA]"
              ],
              "unii": [
                "K16AIQ8CTM"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "PERJETA",
            "drugauthorizationnumb": "125409",
            "drugstructuredosagenumb": "6",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "3",
            "drugintervaldosagedefinition": "803",
            "drugdosagetext": "2L",
            "drugadministrationroute": "065",
            "actiondrug": "5",
            "openfda": {
              "application_number": [
                "BLA125409"
              ],
              "brand_name": [
                "PERJETA"
              ],
              "generic_name": [
                "PERTUZUMAB"
              ],
              "manufacturer_name": [
                "Genentech, Inc."
              ],
              "product_ndc": [
                "50242-145"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "INTRAVENOUS"
              ],
              "substance_name": [
                "PERTUZUMAB"
              ],
              "rxcui": [
                "1298948",
                "1298953"
              ],
              "spl_id": [
                "dfebfe9c-a0c5-41d8-bf11-ed643627e264"
              ],
              "spl_set_id": [
                "17f85d17-ab71-4f5b-9fe3-0b8c822f69ff"
              ],
              "package_ndc": [
                "50242-145-01"
              ],
              "nui": [
                "N0000175661",
                "N0000020008"
              ],
              "pharm_class_epc": [
                "HER2/neu Receptor Antagonist [EPC]"
              ],
              "pharm_class_moa": [
                "HER2/Neu/cerbB2 Antagonists [MoA]"
              ],
              "unii": [
                "K16AIQ8CTM"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "KADCYLA",
            "drugauthorizationnumb": "125427",
            "drugstructuredosagenumb": "3.6",
            "drugstructuredosageunit": "007",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "3",
            "drugintervaldosagedefinition": "803",
            "drugdosagetext": "3L",
            "drugdosageform": "SOLUTION FOR INFUSION",
            "drugadministrationroute": "065",
            "drugindication": "BREAST CANCER METASTATIC",
            "actiondrug": "5",
            "openfda": {
              "application_number": [
                "BLA125427"
              ],
              "brand_name": [
                "KADCYLA"
              ],
              "generic_name": [
                "ADO-TRASTUZUMAB EMTANSINE"
              ],
              "manufacturer_name": [
                "Genentech, Inc."
              ],
              "product_ndc": [
                "50242-087",
                "50242-088"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "INTRAVENOUS"
              ],
              "substance_name": [
                "TRASTUZUMAB EMTANSINE"
              ],
              "rxcui": [
                "1658084",
                "1658087",
                "1658089",
                "1658091"
              ],
              "spl_id": [
                "27ab596b-f625-4866-b65a-54508ffce760"
              ],
              "spl_set_id": [
                "23f3c1f4-0fc8-4804-a9e3-04cf25dd302e"
              ],
              "package_ndc": [
                "50242-088-01",
                "50242-087-01"
              ],
              "unii": [
                "SE2KH7T06F"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ADRIAMYCIN",
            "drugdosagetext": "1L",
            "drugadministrationroute": "065"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "CYTOXAN",
            "drugdosagetext": "1L",
            "drugadministrationroute": "065"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "TAXOTERE",
            "drugdosagetext": "2L",
            "drugadministrationroute": "065"
          }
        ]
      }
    }
  ]
}